LSE - Delayed Quote GBp
Nuformix plc (NFX.L)
At close: 4:01 PM GMT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
--
--
50.0000
195.5500
535.0000
Cost of Revenue
--
--
1.6950
62.3070
333.5950
Gross Profit
--
--
48.3050
133.2430
201.4050
Operating Expense
761.2990
--
1,318.5770
1,505.9210
1,115.4500
Operating Income
-761.2990
--
-1,270.2720
-1,372.6780
-914.0450
Net Non Operating Interest Income Expense
--
--
--
-3.0540
-15.2990
Pretax Income
-761.2990
--
-1,270.2720
-1,375.7320
-929.8820
Tax Provision
-1.1630
--
-161.2790
-122.2350
-173.5060
Net Income Common Stockholders
-760.1360
--
-1,108.9930
-1,253.4970
-756.3760
Diluted NI Available to Com Stockholders
-760.1360
--
-1,108.9930
-1,253.4970
-756.3760
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
708,282.5190
708,282.5190
598,447.7240
580,629.3720
477,064.8220
Diluted Average Shares
708,282.5190
708,282.5190
598,447.7240
580,629.3720
477,064.8220
Total Operating Income as Reported
-761.2990
--
-1,270.2720
-1,372.6780
-914.0450
Total Expenses
761.2990
--
1,320.2720
1,568.2280
1,449.0450
Net Income from Continuing & Discontinued Operation
-760.1360
--
-1,108.9930
-1,253.4970
-756.3760
Normalized Income
-760.1360
--
-1,108.9930
-1,253.4970
-756.3760
Interest Expense
--
--
--
3.0540
15.2990
Net Interest Income
--
--
--
-3.0540
-15.2990
EBIT
-761.2990
--
-1,270.2720
-1,372.6780
-914.5830
EBITDA
-724.4040
--
-1,233.2960
-1,279.6260
-832.8980
Reconciled Cost of Revenue
--
--
1.6950
62.3070
333.5950
Reconciled Depreciation
36.8950
--
36.9760
93.0520
81.6850
Net Income from Continuing Operation Net Minority Interest
-760.1360
--
-1,108.9930
-1,253.4970
-756.3760
Normalized EBITDA
-724.4040
--
-1,233.2960
-1,279.6260
-832.8980
Tax Rate for Calcs
0.0000
--
0.0001
0.0001
0.0002
3/31/2020 - 12/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GDTC CytoMed Therapeutics Limited
2.5400
+6.28%
FUM.L Futura Medical plc
38.40
0.00%
AADI Aadi Bioscience, Inc.
2.1000
-0.94%
AVCT.L Avacta Group Plc
50.00
+3.20%
ALGS Aligos Therapeutics, Inc.
9.92
+6.10%
LRMR Larimar Therapeutics, Inc.
9.12
+11.76%
GUTS Fractyl Health, Inc.
2.4100
-0.41%
OMGA Omega Therapeutics, Inc.
1.1200
-0.88%
LPTX Leap Therapeutics, Inc.
3.4700
-6.47%
TARS Tarsus Pharmaceuticals, Inc.
46.79
-0.02%